Financhill
Buy
79

FOLD Quote, Financials, Valuation and Earnings

Last price:
$14.25
Seasonality move :
4.76%
Day range:
$14.21 - $14.26
52-week range:
$5.51 - $14.36
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
7.29x
P/B ratio:
19.08x
Volume:
5.9M
Avg. volume:
12.8M
1-year change:
45.56%
Market cap:
$4.4B
Revenue:
$528.3M
EPS (TTM):
-$0.04

Amicus Therapeutics, Inc. SEC Filings

Company Filed Form Type Description
FOLD
Amicus Therapeutics, Inc.
05/09/2024 10-Q 10-Q filing on 05/09/2024 View Form
FOLD
Amicus Therapeutics, Inc.
11/08/2023 10-Q 10-Q filing on 11/08/2023 View Form
FOLD
Amicus Therapeutics, Inc.
08/08/2023 10-Q 10-Q filing on 08/08/2023 View Form
FOLD
Amicus Therapeutics, Inc.
05/10/2023 10-Q 10-Q filing on 05/10/2023 View Form
FOLD
Amicus Therapeutics, Inc.
11/07/2022 10-Q 10-Q filing on 11/07/2022 View Form
FOLD
Amicus Therapeutics, Inc.
08/04/2022 10-Q 10-Q filing on 08/04/2022 View Form
FOLD
Amicus Therapeutics, Inc.
05/10/2022 10-Q 10-Q filing on 05/10/2022 View Form
FOLD
Amicus Therapeutics, Inc.
11/09/2021 10-Q 10-Q filing on 11/09/2021 View Form
FOLD
Amicus Therapeutics, Inc.
08/05/2021 10-Q 10-Q filing on 08/05/2021 View Form
FOLD
Amicus Therapeutics, Inc.
05/10/2021 10-Q 10-Q filing on 05/10/2021 View Form
FOLD
Amicus Therapeutics, Inc.
11/05/2020 10-Q 10-Q filing on 11/05/2020 View Form
FOLD
Amicus Therapeutics, Inc.
08/10/2020 10-Q 10-Q filing on 08/10/2020 View Form
FOLD
Amicus Therapeutics, Inc.
05/07/2020 10-Q 10-Q filing on 05/07/2020 View Form
FOLD
Amicus Therapeutics, Inc.
03/02/2020 10-K 10-K filing on 03/02/2020 View Form
FOLD
Amicus Therapeutics, Inc.
11/12/2019 10-Q 10-Q filing on 11/12/2019 View Form
FOLD
Amicus Therapeutics, Inc.
08/08/2019 10-Q 10-Q filing on 08/08/2019 View Form
FOLD
Amicus Therapeutics, Inc.
05/09/2019 10-Q 10-Q filing on 05/09/2019 View Form
FOLD
Amicus Therapeutics, Inc.
02/28/2019 10-K 10-K filing on 02/28/2019 View Form
FOLD
Amicus Therapeutics, Inc.
11/05/2018 10-Q 10-Q filing on 11/05/2018 View Form
FOLD
Amicus Therapeutics, Inc.
08/07/2018 10-Q 10-Q filing on 08/07/2018 View Form
FOLD
Amicus Therapeutics, Inc.
05/09/2018 10-Q 10-Q filing on 05/09/2018 View Form
FOLD
Amicus Therapeutics, Inc.
03/01/2018 10-K 10-K filing on 03/01/2018 View Form
FOLD
Amicus Therapeutics, Inc.
11/08/2017 10-Q 10-Q filing on 11/08/2017 View Form
FOLD
Amicus Therapeutics, Inc.
08/07/2017 10-Q 10-Q filing on 08/07/2017 View Form
FOLD
Amicus Therapeutics, Inc.
05/09/2017 10-Q 10-Q filing on 05/09/2017 View Form
FOLD
Amicus Therapeutics, Inc.
03/03/2017 10-K 10-K filing on 03/03/2017 View Form
FOLD
Amicus Therapeutics, Inc.
03/01/2017 10-K 10-K filing on 03/01/2017 View Form
FOLD
Amicus Therapeutics, Inc.
11/07/2016 10-Q 10-Q filing on 11/07/2016 View Form
FOLD
Amicus Therapeutics, Inc.
08/09/2016 10-Q 10-Q filing on 08/09/2016 View Form
FOLD
Amicus Therapeutics, Inc.
05/03/2016 10-Q 10-Q filing on 05/03/2016 View Form
FOLD
Amicus Therapeutics, Inc.
02/29/2016 10-K 10-K filing on 02/29/2016 View Form

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
85
HUT alert for Dec 25

Hut 8 Corp. [HUT] is up 0.65% over the past day.

Buy
80
TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy
63
GPCR alert for Dec 25

Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock